Skip to main content
SpringerLink
Log in

Enzymes in the Dissolution Testing of Gelatin Capsules

  • Review Article
  • Theme: Recent Advances in Dissolution and In Vitro Release of Dosage Forms
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Gelatin capsules are a widely used dosage form both for pharmaceutical drug products as well as dietary supplements. Gelatin in the presence of certain compounds, mainly aldehydes, or in high humidity and high temperature conditions can cross-link. Cross-linking involves covalent bonding of the amine group of a lysine side chain of one gelatin molecule to a similar amine group on another molecule. The covalent bonding is, for practical purposes, irreversible. Cross-linking results in the formation of a pellicle on the internal or external surface of the gelatin capsule shell that prevents the capsule fill from being released. In vitro dissolution testing of cross-linked gelatin capsules can result in slower release of the drug or no release at all. The data obtained by the Gelatin Capsule Working Group, created in the early 90s to investigate noncompliance of gelatin capsules, was used to establish the type and amounts of enzymes that can be added to the dissolution medium in the case of test failure to the presence of cross-linking in the gelatin. The two-tier dissolution testing was included in the US Pharmacopeia and it recommends the addition of pepsin (pH below 6.8) or pancreatin (pH above 6.8) to the medium depending on its pH. Pepsin shows good protease activity up to pH 4 and pancreatin above pH 6 leaving a gap where neither one has good activity. Possible proteolytic enzymes that could be used for the pH range 4–6.8 could be papain or bromelain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Marques MRC, Cole E, Kruep D, Gray V, Murachanian D, Brown WE, et al. Liquid-filled gelatin capsules. Pharm Forum. 2009;35(4). www.usppf.com.

  2. Podczeck F, Jones BE. Pharmaceutical capsules. London: Pharmaceutical Press; 2004.

    Google Scholar 

  3. Hu J, Kyad A, Ku V, Zhou P, Cauchon N. A comparison of dissolution testing on lipid soft gelatin capsules using USP apparatus 2 and apparatus 4. Dissol Technol. 2005;12(2):6–9.

    Article  CAS  Google Scholar 

  4. Meyer MC, Strughn AB, Mhatre RM, Hussain A, Sha VP, Bottom CB, et al. The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules. Pharm Res. 2000;17(8):962–6.

    Article  CAS  PubMed  Google Scholar 

  5. Chang CK, Alvarez-Nunez FA, Rinella Jr JV, Magnusson LE, Sued K. Roller compaction, granulation and capsule product dissolution of drug formulations containing a lactose or mannitol filler, starch, and talc. AAPS PharmSciTech. 2008;9(2):597–604.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Elmeshad AN, Darwish MK. Stability studies of the effect of crosslinking on hydrochlorothiazide release. Drug Discov Ther. 2009;3(3):136–42.

    CAS  PubMed  Google Scholar 

  7. St. Clair MJ, Purdie J, Hu Y, McGeough P. The effect of cross-linking on the in vitro disintegration of hard gelatin capsules. J Pharm Pharmacol. 2010;62(10):1235–6.

    CAS  Google Scholar 

  8. USP. USP 36 – NF 31. <711 > Dissolution. Rockville: US Pharmacopeial Convention; 2013. p. 307.

  9. <1094 > Capsules—dissolution testing and related quality attributes. Pharm Forum. 2013;39(3). www.usppf.com.

  10. Cole ET, Cade D, Benameur H. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Adv Drug Deliv Rev. 2008;60:747–56.

    Article  CAS  PubMed  Google Scholar 

  11. Rose PI. Gelatin. In: The theory of the photographic process. 4th ed. New York: Macmillan Publ. Co.; 1977. p. 51–67.

  12. Kalantzi L, Page R, Nicolaides E, Digenis G, Reppas C. In vitro methods can forecast the effects of intragastric residence on dosage form performance. Eur J Pharm Sci. 2008;33:445–51.

    Article  CAS  PubMed  Google Scholar 

  13. Jones BE. How gelatin and hypromellose capsules differ in product release during dissolution testing. Tablets & Capsules. 2010; January: 16–19.

  14. Aikman M et al. Collaborative development of two-tier dissolution testing for gelatin capsules and gelatin-coated tablets using enzyme-containing media. Pharm Forum. 1998;24(5):704–7050.

    Google Scholar 

  15. USP. USP 24 – NF 19, First supplement. <711 > Dissolution. Rockville: US Pharmacopeial Convention; 2000. p. 2696

  16. Singh S, Rao KVR, Venugopal K, Manikandan R. Alteration in dissolution characteristics of gelatin-containing formulations. Pharm Technol. 2002;26:36–58.

    CAS  Google Scholar 

  17. Tengroth C, Gasslander U, Anderson FO, Jacobsson SP. Cross-linking of gelatin capsules with formaldehyde and other aldehydes: an FTIR spectroscopy study. Pharm Dev Technol. 2005;10:405–12.

    Article  CAS  PubMed  Google Scholar 

  18. Song X, Cui Y, Xie M. Gelatin capsule shell cross-linking. Tier II dissolution method development in the presence of sodium lauryl sulfate. Pharm Technol. 2011;35(5):62–8.

    CAS  Google Scholar 

  19. Piper DW, Fenton BH. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut. 1965;6:506–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. USP. USP 36 – NF 31. Purified pepsin. Rockville: US Pharmacopeial Convention; 2013. p. 1181.

  21. Kristo K, Pintye-Hodi K. Effects of pharmaceutical processing on pepsin activity during the formulation of solid dosage forms. Pharm Dev Technol. 2013;18(1):17–21.

    Article  CAS  PubMed  Google Scholar 

  22. Berdutina AV, Neklyudov AD, Ivankin AI, Karpo BS, Mitaleva SI. Comparison of proteolytic activities of the enzyme complex from mammalian pancreas and pancreatin. Appl Biochem Microbiol. 2000;36:363–7.

    Article  Google Scholar 

  23. USP. USP 36 – NF 31. Pancreatin. Rockville: US Pharmacopeial Convention; 2013. p. 4672.

  24. Azarkan M, El Moussaoui A, van Wuytswinkel D, Dehon G, Looze Y. Fractionation and purification of the enzymes stored in the latex of Carica papaya. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;790(1–2):229–38.

    Article  CAS  PubMed  Google Scholar 

  25. Arnon R. Papain. In: Perlmann G, Lorand L, editors. Method in enzymology, vol. 19. New York: Academic; 1970. p. 226–45.

    Google Scholar 

  26. Kimmel JR, Smith EL. The properties of papain. In: Nord FF, editor. Advances in enzymology and related areas of molecular biology, vol. 19. New York: Interscience Publ; 1957. p. 267–333.

    Google Scholar 

  27. Lineweaver H, Schwimmer S. Some properties of crystalline papain. Enzymologia. 1941;10:81–6.

    CAS  Google Scholar 

  28. Hoover SR, Kokes ELC. Effect of pH upon proteolysis by papain. J Biol Chem. 1947;167(1):199–207.

    CAS  PubMed  Google Scholar 

  29. USP. USP 36 – NF 31. Papain. Rockville: US Pharmacopeial Convention; 2013. p. 4186.

  30. Corzo CA, Waliszewski KN, Welti-Chanes J. Pineapple fruit bromelain affinity to different protein substrates. Food Chem. 2012;133(3):631–5.

    Article  CAS  Google Scholar 

  31. Lu X, Xiao B, Lo L, Bolgar MS, Lloyd DK. Development of a two-step tier-2 dissolution method for blinded overencapsulated erlotinib tablets using UV fiber optic detection. J Pharm Biomed Anal. 2011;56:23–9.

    Article  CAS  PubMed  Google Scholar 

  32. Pennings FH, Kwee BLS, Vromans H. Influence of enzymes and surfactants on the disintegration behavior of cross-linked hard gelatin capsules during dissolution. Drug Dev Ind Pharm. 2006;32:33–7.

    Article  CAS  PubMed  Google Scholar 

  33. USP. USP 36 – NF 31. The dissolution procedure: development and validation <1092>, Rockville: US Pharmacopeial Convention; 2013. p. 735.

  34. Gallery J, Han JH, Abraham C. Pepsin and pancreatin performance in the dissolution of crosslinked gelatin capsules from pH 1 to 8. Pharm Forum. 2004;30(3):1084–1089. www.usppf.com.

  35. Bottom CB, Clark M, Carstensen JT. Dissolution testing of soft shell capsules—acetaminophen and nifedipine. J Pharm Sci. 1997;86(9):1057–61.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. US Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD, 20852, USA

    Margareth R. C. Marques

Authors
  1. Margareth R. C. Marques
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Margareth R. C. Marques.

Additional information

Guest Editor: Susan D'Souza

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marques, M.R.C. Enzymes in the Dissolution Testing of Gelatin Capsules. AAPS PharmSciTech 15, 1410–1416 (2014). https://doi.org/10.1208/s12249-014-0162-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-014-0162-3

KEY WORDS

Search

Navigation